Abstract:Objective To comprehend the development status quo of the management specialty of high-risk medications, to elucidate the trend on relational research field, and to provide a theoretical basis for rational clinical medication. Methods The literature published domestically and abroad was reviewed, the development status on the management specialty of high-risk medications was reviewed, an idea of future development on the research field of high-risk medications was formed, and responsibility of clinicians on high-risk medication management was elucidated. Results The research work of high-risk medication management is still in its infancy in China. Its studies were dispersed in certain areas, with remarkable repetition, and large gaps were found in the research field as compared with that in developed countries. Development of the said discipline and its related research should be strengthened at the present and henceforth. The corresponding society should play a leading role in the development of the discipline. Systemic analysis and comprehensive evaluation should be implemented by applying pharmaceutical epidemiology and evidence-based pharmacology methodology. The catalogue of high-risk medications and the evidence-based guideline of injury prevention against high-risk medications should be established, and the control regulation of high-risk medications should be formulated. The research achievements should be assessed and improved, and then disseminated and applied. An integrated and scientific theoretical system of high-risk medications management should be established, which should contain institutional framework, education, research, and management regulation. Conclusions A joint participation of several disciplines and professions is needed in the research work of high-risk medications management in order to guide the safe and rational use of the drugs. The responsibilities of different professionals, including physicians, pharmacists, nurses and administrator should be stressed in the research work of high-risk medications management in order to raise the safety and optimal use of the drugs.

The Responsibilities of Pharmaceutical Enterprises in Drug Risk Management

Exploring of the Risk Management System on Post-market Drug in the Enterprise

Comparative Analysis on the Practice of Drug Risk Management in China

Research on the Risk Management of Pharmaceutical Circulation Enterprises -- Taking Sinopharm Holding Co., Ltd as an Example Based on Data Analysis

Realization of Social Responsibility of Pharmaceutical Enterprises under Public Health Crisis

Present situation and development trend of the management specialty of high-risk medication——Discussion on the physician's responsibility in high-risk medication management

The Enl Ightment of FDA’s Drug Safety Risk Management Final Guidelines to Drug Safety Risk Management in China

Thinking of Drug Safety from Risk Society Theory Perspective

Study on Risk Management of Drug Damage Events under the System of Marketing Authorization Holder in Germany and Japan

Risk management of chinese-western medicine compound preparation

Study on Risk Management Plans Based on the Hospital Drugs Supply Chain

The Risk Control During New Drug Research

Chinese Drug Sefety Risk and Crisis Control,Achievement Problems and Solutions

The Risks of Drug Therapy and It's Managements

Bibliometrics Analysis on Drug Risk Management in China

Risk Management of Chinese Medicine Preparations Containing Toxic Herbs

IMPROVEMENT OF THE QUALITY MANAGEMENT SYSTEM AT THE PHARMACEUTICAL ENTERPRISE THROUGH THE INTRODUCTION OF EFFECTIVE RISK MANAGEMENT

A Practical Discussion of Risk Management for Manufacturing of Pharmaceutical Products

A Systematic Review and Qualitative Analysis or the Definition and Scope of Drug Safety in China

Probe into Current Drug Safety Responsibility System in China

Enterprise Risk Management in the Specialty Chemical Distribution Sector: A Literature Review